A filing-led Datavault AI deep dive covering Q1 2026 results, product architecture, RWA tokenization, SanQtum GPU infrastructure, NYIAX/CyberCatch/DelivMeds optionality, HELMEX structured financing, dilution, and the proof gates that matter next.
All published reports.
Search curated company theses by ticker, product, catalyst, risk, topic, sector, article, or slide deck.
Research reports
Company evaluations, product due diligence, and thesis updates with article and deck views.
Nano Nuclear Energy has cash, a KRONOS MMR NRC review milestone, and a nuclear logistics acquisition, but investors still need revenue proof.
Momentus says its cash position has jumped to about $76 million with no debt. The real question is whether Vigoride progress can become revenue before share-count math absorbs the upside.
This Hidden Space Supplier Has a Real Receipt
A hidden-identity GoGlides receipts explainer on Filtronic, profitability, cash, SpaceX orders, and customer-concentration risk.
AI data centers need power and cooling before they need another software demo.
Revvity is trying to prove the post-spin model can protect margins while faster life-science competitors chase growth.
Rocket Lab is scaling space systems and launch operations, but the financial question is how much R&D the model can absorb.
Rocket Lab has launch credibility, but Neutron must prove it can move the company beyond small-launch economics.
This Space Infrastructure Stock Has a Cash Test
A hidden-identity GoGlides receipts explainer on Redwire's backlog, defense-UAS wins, cash flow, and dilution risk.
SoFi is growing across lending, financial services, and technology, but credit risk decides how durable the growth is.
Redwire has fresh space and drone headlines, but the real RDW proof gate is whether record backlog converts into profitable revenue and cash without new dilution pressure.
Small modular reactors sound like a data-center power answer, but NuScale still has to prove commercialization.
AI-server demand is large, but the liquidity story is about cash, working capital, and volatility.
This Space Service Story Has a Balance Sheet Twist
A hidden-identity GoGlides receipts explainer on Sidus Space, balance sheet strength, small revenue, and dilution risk.
Thermo Fisher and Agilent both use service ecosystems, but capital allocation decides which model compounds better.
AI chips still need to be tested, and Teradyne sits in that less flashy bottleneck.
Palantir's index-inclusion narrative can attract attention, but institutional flow only matters if business fundamentals keep confirming the story.
Palantir is a profitable AI software company, but government contract quality matters more than headlines.
Planet posted record revenue and a much bigger cash position, but retail investors still have to decide whether backlog can turn into cleaner profits.
A hidden-identity GoGlides receipts explainer on Momentus, the space tow-truck idea, cash, losses, and dilution risk.
Joby needs certification progress to arrive before liquidity concerns dominate the air-taxi story.
Joby has an ambitious air-taxi network vision, but the financial runway comes before scale.
Intuitive Surgical's moat depends on whether da Vinci 5 deepens installed-base economics instead of just refreshing hardware.
Intuitive Surgical is not only a robot sale story; the installed base creates recurring instruments, accessories, and service economics.
IonQ needs to prove its quantum advantage can survive competition from larger tech platforms with deeper budgets.
IonQ benefits from quantum-computing excitement, but investors need to separate scientific progress from commercial revenue.
Hims is using GLP-1 weight loss to expand the platform, but the quality test is retention and cash flow.
Grab is trying to turn Southeast Asia scale into durable profitability.
Enphase has strong technology, but residential solar demand is sensitive to financing costs.
A beginner-friendly, fact-based DVLT brief on HELMEX, the UK address controversy, the non-binding $2B term sheet, the $25M payment, dilution, and board rights.
Coherent Corp Analysis: Tracking Laser Technology Adoption Within Next Generation Optical Networking
Coherent sits in lasers, optics, and networking components that matter as data traffic explodes.
Ginkgo has moved from broad synthetic-biology promise toward a harder profitability test.
Danaher and Agilent both sell into durable lab workflows, but the winner depends on recurring mix, margin quality, and cash conversion.
BitMine priced an upsized preferred-stock deal, and the real question is whether ETH treasury growth can beat a new preferred dividend claim that sits ahead of common shareholders.
Bio-Rad has diagnostics exposure, but the market may be questioning whether the segment deserves a peer-growth multiple.
AST SpaceMobile is trying to connect ordinary phones from space, but the financial story is still early and capital intensive.
ASML's High-NA lithography story is about whether monopoly-like tools keep controlling the next chip node.
Arm benefits when customers design custom chips instead of relying only on traditional merchant silicon.
ARM Holdings Licensing: Measuring Royalty Growth Amidst The Global Shift Toward Custom Silicon
Arm benefits when more custom chips use its architecture, but royalty growth must justify the valuation.
Archer's aircraft range matters, but infrastructure partnerships decide whether an air-taxi network can actually launch.
Agilent's CrossLab segment is becoming the quiet efficiency layer for regulated pharma labs: services, consumables, software, automation, and asset monitoring. The proof gate is whether CrossLab can keep growing while margin stays strong.
Datavault AI's June 4 Form 8-K turns the structured financing story into a cash, dilution, control, and approval proof gate.
A filing-backed DVLT update explaining Vivasor's Form 3 initial position, Form 4 20M-share sale, Schedule 13G remaining stake, and the proof gate investors should monitor.
Hims & Hers completed the Eucalyptus acquisition on June 2, 2026. The close upgrades the scale story, but the real proof still has to show up in international revenue mix, retention, margins, and cash flow.
A beginner-friendly translation of Datavault AI's $2.0B structured financing term sheet, including term sheet status, dilution, tranches, the $25M payment, share-value math, and shareholder proof gates.
Zeta reported 50% Q1 revenue growth, raised 2026 guidance again, and launched Athena by Zeta. The proof gate is organic growth, super-scaled customers, adjusted EBITDA margin, and free cash flow.
Q1 2026 revenue beat, raised revenue guidance, and the first sixth-generation 256-qubit system sale. The proof gate is RPO conversion, organic revenue growth, and adjusted EBITDA loss discipline.
Grab reported Q1 2026 revenue growth, record adjusted EBITDA, and stronger on-demand GMV. The proof gate is adjusted EBITDA, adjusted free cash flow, loan quality, and incentive discipline.